JP7200261B2 - エラゴリクスを作製するプロセス - Google Patents

エラゴリクスを作製するプロセス Download PDF

Info

Publication number
JP7200261B2
JP7200261B2 JP2020550593A JP2020550593A JP7200261B2 JP 7200261 B2 JP7200261 B2 JP 7200261B2 JP 2020550593 A JP2020550593 A JP 2020550593A JP 2020550593 A JP2020550593 A JP 2020550593A JP 7200261 B2 JP7200261 B2 JP 7200261B2
Authority
JP
Japan
Prior art keywords
compound
formula
elagolix
reacting
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020550593A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021505683A (ja
JP2021505683A5 (https=
Inventor
ピーシュー リー
ペン ワン
シャンヨン グー
ハイロン ヤン
ジョン ワン
チャンファ ジャン
ユアンファ リュー
フイ シア
Original Assignee
スージョウ ポンシュー ファーマテック カンパニー リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN201711263255.7A external-priority patent/CN109867631A/zh
Priority claimed from CN201810042494.8A external-priority patent/CN110128355A/zh
Priority claimed from CN201810941650.4A external-priority patent/CN110835302A/zh
Priority claimed from CN201811104129.1A external-priority patent/CN110938037A/zh
Application filed by スージョウ ポンシュー ファーマテック カンパニー リミテッド filed Critical スージョウ ポンシュー ファーマテック カンパニー リミテッド
Publication of JP2021505683A publication Critical patent/JP2021505683A/ja
Publication of JP2021505683A5 publication Critical patent/JP2021505683A5/ja
Application granted granted Critical
Publication of JP7200261B2 publication Critical patent/JP7200261B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/44—Palladium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J25/00—Catalysts of the Raney type
    • B01J25/02—Raney nickel
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/06—1,3-Thiazines; Hydrogenated 1,3-thiazines not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2020550593A 2017-12-05 2018-12-03 エラゴリクスを作製するプロセス Active JP7200261B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
CN201711263255.7 2017-12-05
CN201711263255.7A CN109867631A (zh) 2017-12-05 2017-12-05 一种含有6-甲基尿嘧啶结构化合物的制备方法
CN201810042494.8A CN110128355A (zh) 2018-01-17 2018-01-17 一种含有6-甲基尿嘧啶结构化合物的制备方法
CN201810042494.8 2018-01-17
CN201810941650.4A CN110835302A (zh) 2018-08-17 2018-08-17 一种恶拉戈利及其钠盐的中间体及其制备方法
CN201810941650.4 2018-08-17
CN201811104129.1 2018-09-21
CN201811104129.1A CN110938037A (zh) 2018-09-21 2018-09-21 一种依拉戈利钠盐药物中间体的制备方法
PCT/US2018/063682 WO2019112968A1 (en) 2017-12-05 2018-12-03 Processes to produce elagolix

Publications (3)

Publication Number Publication Date
JP2021505683A JP2021505683A (ja) 2021-02-18
JP2021505683A5 JP2021505683A5 (https=) 2022-01-11
JP7200261B2 true JP7200261B2 (ja) 2023-01-06

Family

ID=66751637

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020550593A Active JP7200261B2 (ja) 2017-12-05 2018-12-03 エラゴリクスを作製するプロセス

Country Status (5)

Country Link
US (1) US11377426B2 (https=)
EP (1) EP3720845A4 (https=)
JP (1) JP7200261B2 (https=)
TW (2) TW202030177A (https=)
WO (1) WO2019112968A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7200261B2 (ja) 2017-12-05 2023-01-06 スージョウ ポンシュー ファーマテック カンパニー リミテッド エラゴリクスを作製するプロセス
EP3826638A4 (en) * 2018-07-23 2022-04-06 Abbvie Inc. ELAGOLIX SODIUM COMPOSITIONS AND RELATED METHODS
ES2802815B2 (es) 2019-07-12 2022-03-14 Moehs Iberica Sl Sal clorhidrato de 3-[2(r)-amino-2-feniletil]-5-(2-fluoro-3-metoxifenil)-1-[2-fluoro-6-(trifluorometil)bencil]-6-metil-1h-pirimidin-2,4(1h,3h)-diona (i) en forma solida, procedimiento para su preparacion y uso de la misma en la sintesis de elagolix
TWI755055B (zh) * 2019-09-18 2022-02-11 台灣神隆股份有限公司 用於製備惡拉戈利鈉及其中間體的方法
CN116283797B (zh) * 2022-12-30 2024-11-29 浙江车头制药股份有限公司 一种噁拉戈利钠的合成方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005516986A (ja) 2002-02-08 2005-06-09 ブリストル−マイヤーズ　スクイブ　カンパニー （オキシム）カルバモイル脂肪酸アミド加水分解酵素インヒビター
JP2007521309A (ja) 2003-07-07 2007-08-02 ニューロクライン バイオサイエンシーズ， インコーポレイテッド 性腺刺激ホルモン放出ホルモンレセプターアンタゴニストとしてのピリミジン−２，４−ジオン誘導体
WO2009062087A1 (en) 2007-11-07 2009-05-14 Neurocrine Biosciences, Inc. Processes for the preparation of uracil derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998004509A1 (en) 1996-07-30 1998-02-05 Nippon Soda Co., Ltd. 2,3-dihalogeno-6-trifluoromethylbenzene derivatives and processes for the preparation thereof
GB0711521D0 (en) 2007-06-14 2007-07-25 Glaxo Group Ltd Novel compounds
WO2010115098A2 (en) 2009-04-03 2010-10-07 The Scripps Research Institute Palladium-catalyzed ortho-fluorination
JP6697809B2 (ja) 2015-03-06 2020-05-27 ファーマケア，インク． フッ素化リシルオキシダーゼ様２阻害剤とその使用
JP7200261B2 (ja) 2017-12-05 2023-01-06 スージョウ ポンシュー ファーマテック カンパニー リミテッド エラゴリクスを作製するプロセス

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005516986A (ja) 2002-02-08 2005-06-09 ブリストル−マイヤーズ　スクイブ　カンパニー （オキシム）カルバモイル脂肪酸アミド加水分解酵素インヒビター
JP2007521309A (ja) 2003-07-07 2007-08-02 ニューロクライン バイオサイエンシーズ， インコーポレイテッド 性腺刺激ホルモン放出ホルモンレセプターアンタゴニストとしてのピリミジン−２，４−ジオン誘導体
WO2009062087A1 (en) 2007-11-07 2009-05-14 Neurocrine Biosciences, Inc. Processes for the preparation of uracil derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Tetrahedron Letters，2013年，Vol.54, No.45，pp.6053-6056

Also Published As

Publication number Publication date
US20210214318A1 (en) 2021-07-15
US11377426B2 (en) 2022-07-05
EP3720845A1 (en) 2020-10-14
TW202030177A (zh) 2020-08-16
TW201925159A (zh) 2019-07-01
WO2019112968A1 (en) 2019-06-13
JP2021505683A (ja) 2021-02-18
TWI693208B (zh) 2020-05-11
EP3720845A4 (en) 2021-09-01

Similar Documents

Publication Publication Date Title
JP7200261B2 (ja) エラゴリクスを作製するプロセス
AU2010232559B2 (en) Method of preparing an inhibitor of cytochrome P450 monooxygenase, and intermediates involved
WO2006054151A1 (en) Synthesis of 5-bromo-4-methyl-pyridin-3-ylmethyl)-ethyl-carbamic acid tert-butyl ester
CN111527067B (zh) 1－[5－(2－氟苯基)－1－(吡啶－3－基磺酰基)－1h－吡咯－3－基]－n－甲基甲胺单富马酸盐的制造法
CN108148044B (zh) 酰胺类化合物及该化合物制备富马酸沃诺拉赞的方法
EP3706740A1 (en) Processes to produce acalabrutinib
CN108727224B (zh) 药物合成用中间体的制备方法
CN109232222B (zh) 一种(e)-辛-4-烯-1,8-二酸的制备方法
CN107286070A (zh) (r)‑2‑(2,5‑二氟苯基)吡咯烷的合成方法及中间体
CN109280055A (zh) 麦角类生物碱的不对称合成方法
WO2014206257A1 (zh) 一种2-羧酸吡咯烷衍生物的制备方法
KR102919305B1 (ko) 치환된 2-[2-(페닐)에틸아미노]알칸아미드 유도체를 제조하는 방법
CN109369618B (zh) 一锅烩制备2-氯-5-（（2-（硝基亚甲基）咪唑啉-1-基）甲基）吡啶的方法
KR102389716B1 (ko) 인돌 또는 인다졸 화합물의 제조방법
JP7854496B2 (ja) ４－メトキシピロール誘導体とその合成方法
KR100856133B1 (ko) 아토르바스타틴의 개선된 제조방법
WO2022152090A1 (en) Process for preparing (s)-1-(1-acryloylpyrrolidin-3-yl)-3-((3,5-dimethoxyphenyl) ethynyl)-5-(methylamino)-1h-pyrazole-4-carboxamide
CN110092753B (zh) 一种合成3-氮杂二环[4．1．0]庚烷-2-甲酸及其盐酸盐的制备方法
US7122674B2 (en) Process for preparing high-purity hydroxyindolylglyoxylamides
CN119462638A (zh) 一种cdk 4/6抑制剂的制备方法
CN120607452A (zh) 一种高效合成Kukoamine B和Kukoamine D及其衍生物的新方法
CN121135607A (zh) N-甲基-n-乙炔基对甲苯磺酰胺的制备方法及应用
KR101325589B1 (ko) 1-알킬-2-(2-아미노에틸)피롤리딘의 제조방법
CN120025261A (zh) 一种2-氨酰基取代的l-苯丙氨酸的合成方法
TW202237613A (zh) 製備４－（３，５－二氟苯基）－Ｎ－［３－（６－甲基嘧啶－４－基）－３－氮雜雙環［３．２．１］辛－８－基］－６，７－二氫－５Ｈ－［１，２，４］三唑并［１，５－ａ］嘧啶－２－胺之方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211202

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20211202

TRDD Decision of grant or rejection written
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20221114

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20221121

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20221221

R150 Certificate of patent or registration of utility model

Ref document number: 7200261

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250